UVA

In this week’s issue of The Savvy Diabetic:  1st Rapid-Acting Biosimilar Insulin Approved UVa AI-Powered Insulin Delivery Susvimo for Diabetic Macular Edema Oral Insulin Prevention Trial (PDF) GLP-1 Agonists Increased …

CHARLOTTESVILLE, Va. (WVIR) – UVA experts are testing different methods in a program to help people with type 2 diabetes. They are trying to find approaches that don't require weight …

The technology was patented through the UVA Licensing & Ventures Group and was limited to ages 6 and up. But now, even her two-year-old child with type 1 diabetes can …